Skip to content
info@acplgroupindia.co.in +91-9266665201 Mon – Sat: 10:00 AM – 6:00 PM
Accredited Consultant
  • Home
  • About
  • Services

    • Regulatory Services

      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology

    • Specialized Services

      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials

    • More Services

      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • Newsletter
    • Volume 22
    • Volume 23
    • Volume 24
    • Volume 25
    • Volume 26
    • Volume 27
    • Volume 28
    • Volume 29
    • Volume 30
    • Volume 31
  • Blog
  • Contact
Get Started
Accredited Consultant
  • Home
  • About
  • Services
    • Regulatory Services
      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology
    • Specialized Services
      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials
    • More Services
      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • Newsletter
    • Volume 22
    • Volume 23
    • Volume 24
    • Volume 25
    • Volume 26
    • Volume 27
    • Volume 28
    • Volume 29
    • Volume 30
    • Volume 31
  • Blog
  • Contact
Call Us: +91-9266665201 info@acplgroupindia.co.in
  1. Home
  2. Tagged: materiovigilance

Tagged: materiovigilance

Regulatory updates, compliance insights, and industry analysis from the ACPL team.

Knowledge Base
Oct 19, 2026

CDSCO’s 2026 Post-Market Surveillance Overhaul: What’s Changed

CDSCO has tightened post-market surveillance for medical devices in 2026 — new MDSW guidance, 48-hour recall rules, and risk-based audits.…

Read More
Knowledge Base
Aug 24, 2026

MvPI Compliance Alert 2026: New Adverse Event Reporting Rules

IPC's January 2026 directive tightens adverse event reporting for medical device MAHs via ADRMS. Here's what license holders must do…

Read More
Accredited Consultant

India's trusted pharma regulatory affairs consultancy. Over 25 years helping businesses navigate CDSCO, FSSAI, BIS, and all major Indian regulatory frameworks.

Quick Links

  • About ACPL
  • Our Services
  • India Entry Strategy
  • Insights & Blog
  • Contact Us
  • Careers

Key Services

  • CDSCO Registration
  • FSSAI Licensing
  • BIS Certification
  • Pharmacovigilance
  • Clinical Trials
  • EPR Registration

Contact Us

  • B-3, Sector-6, Noida – 201301, Uttar Pradesh, India
  • +91-9266665201
    +91-9310040434
  • info@acplgroupindia.co.in
  • Mon – Sat: 10:00 AM – 6:00 PM

© 2026 Accredited Consultants Private Limited. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
Scroll to Top